Skip to main content
. 2012 Jan 25;5(4):1023–1026. doi: 10.3892/mmr.2012.767

Figure 1.

Figure 1

FACS comparison of the stem cell markers in fibroblast-like synoviocytes (FLSs) from rheumatoid arthritis (RA) or osteoarthritis (OA) patients, normal dermal fibroblasts (DF) and bone marrow mesenchymal stem cells (BMMSC). The data shown are representative of three independent experiments with similar results.